Cargando…

Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study

To evaluate associations among coagulation-related variables, resolution of disseminated intravascular coagulation (DIC) and mortality, we retrospectively investigated 123 patients with sepsis-induced DIC treated with recombinant human soluble thrombomodulin (rTM). Changes in coagulation-related var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitaka, Chieko, Kawagoe, Izumi, Satoh, Daizoh, Hayashida, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646186/ https://www.ncbi.nlm.nih.gov/pubmed/34859680 http://dx.doi.org/10.1177/10760296211050356

Ejemplares similares

Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010)

Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Murao, Atsushi, et al.
Publicado: (2022)

Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2015)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation
por: Suzuki, Y, et al.
Publicado: (2013)

Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2013)

Use of Recombinant Human Soluble Thrombomodulin in Patients with Sepsis-Induced Disseminated Intravascular Coagulation after Intestinal Perforation
por: Tagami, Takashi, et al.
Publicado: (2015)

The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study
por: Yoshihara, Masato, et al.
Publicado: (2015)

Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis
por: Okuda, Atsushi, et al.
Publicado: (2018)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia
por: Ookura, Miyuki, et al.
Publicado: (2018)

Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
por: Asai, Yuki, et al.
Publicado: (2020)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yoshimura, Jumpei, et al.
Publicado: (2015)

Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study
por: Kato, Takahiro, et al.
Publicado: (2013)

TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin
por: Takayama, Yusuke, et al.
Publicado: (2017)

Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation
por: Eguchi, Yutaka, et al.
Publicado: (2014)

Effect of Thrombomodulin Alfa on Disseminated Intravascular Coagulation in Patients with Lung Cancer
por: Nakano, Kentaro, et al.
Publicado: (2017)

Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
por: Takahashi, Kyosuke, et al.
Publicado: (2021)

Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Akahoshi, Tomohiko, et al.
Publicado: (2022)

Sepsis and disseminated intravascular coagulation
por: Okamoto, Kohji, et al.
Publicado: (2016)

Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors
por: Ouchi, Kota, et al.
Publicado: (2018)

Therapeutic Plasma Exchange Protects Patients with Sepsis-Associated Disseminated Intravascular Coagulation by Improving Endothelial Function
por: Weng, Junting, et al.
Publicado: (2021)

Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation
por: Ikezoe, Takayuki
Publicado: (2015)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014)

Comparison of desflurane and propofol in the speed and the quality of emergence from anesthesia in patients undergoing lung cancer surgery—a prospective, randomized study
por: Kawagoe, Izumi, et al.
Publicado: (2022)

Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2019)

Pharmacokinetics of Standard- and Reduced-Dose Recombinant Human Soluble Thrombomodulin in Patients with Septic Disseminated Intravascular Coagulation during Continuous Hemodiafiltration
por: Watanabe, Eizo, et al.
Publicado: (2017)

Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient
por: Morino, Kahori, et al.
Publicado: (2018)

Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database
por: Yamaguchi, Takuhiro, et al.
Publicado: (2018)

Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
por: Nakahara, Kazunari, et al.
Publicado: (2013)

Preoperative disseminated intravascular coagulation complicated by thoracic aortic aneurysm treated using recombinant human soluble thrombomodulin: A case report
por: Tanigawa, Yoshinori, et al.
Publicado: (2021)

Use of Recombinant Human Soluble Thrombomodulin in a Patient with Disseminated Intravascular Coagulation Associated with Abdominal Aortic Aneurysm: A Case Report
por: Yamamoto, Yohei, et al.
Publicado: (2023)

Sepsis-associated disseminated intravascular coagulation and its differential diagnoses
por: Iba, Toshiaki, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation in Sepsis and Associated Factors
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014)

The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
por: Akatsuka, Masayuki, et al.
Publicado: (2020)

Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation
por: Hwang, Sang Mee, et al.
Publicado: (2011)

Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation
por: Morita, Nozomi, et al.
Publicado: (2018)

Sepsis-Associated Disseminated Intravascular Coagulation and Thromboembolic Disease
por: Semeraro, Nicola, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h57lebq79lb6er7ie0o365bo3l